After conducting serveral clinical trials on patients with Hodgkin's Lymphoma, researchers believe that nivolumab is the new weapon against cancer. Experts report a breakthrough regarding Hodgkin’s Lymphoma after conducting a clinical trial on patients with resistant forms of the disease. This new compound used in the clinical trial, allows the immune system to efficiently recognize and destroy … [Read more...]